Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Lagercrantz Group in connection with the acquisition of Vanpee in Norway and Sweden
Mandate

Vinge advises Lagercrantz Group in connection with the acquisition of Vanpee in Norway and Sweden

July 06, 2012

Vinge is advising Lagercrantz Group AB in connection with the acquisition of the entire issued share capital in Vanpee Norge AS and Vanpee AB. The Vanpee companies are value added distributors within the lighting industry with leading component manufacturers within the portfolio and have an aggregate annual turnover of approximately SEK 75 million. The transaction is subject to the consent of the Norwegian Competition Authority and other customary conditions to closing.

Vinge’s team consists of partner Johan Winnerblad and associate Louise Markgren.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026